ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

©Martial Red/Shutterstock.com

The ICD-10 transition will continue into the next year for practices. Here are some tips you’ll need to take in 2016.

©Pressmaster/Shutterstock.com

With a dearth of coders thanks to the ICD-10 transition, some practices find that training current staff is the best way to get good coders.

Health care reform, the patient-centered medical home, and the impact of environmental change on global health are just a few of the topics to be discussed at the Internal Medicine 2009 Medicine 2009 in Philadelphia this week.

This slide show highlights some of this year’s FDA approvals of cancer treatments, including new therapies and indications for breast cancer, lung cancer, and various blood cancers, as well as the first approval based not on disease site but rather by a tumor marker.

Adding midostaurin to chemotherapy prolonged survival in younger adult patients with acute myeloid leukemia and a FLT3 mutation, according to a randomized trial.

©s_bukley/Shutterstock.com

Small practices can benefit from partnering with an IT partner to fit their needs, here are some tips on choosing that partner.

50-year-old diabetic patient presented with fever, dysuria, and abdominal pain.

Outsiders’ influence on radiology.

©Orhan Cam-shutterstock

The Senate repeal and replace of Obamacare was published this week and like the House version, it faces strong resistance from medical groups.

Adding the novel CD20 inhibitor ublituximab to ibrutinib offered improved response rates and greater depth of response over ibrutinib alone in patients with relapsed/refractory chronic lymphocytic leukemia.

An anti–PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.

Long-term survivors of wild-type KRAS colorectal cancer tumors had significantly improved survival with regular use of nonsteroidal anti-inflammatory drugs.

©hands-gst-shutterstock.com

A doctor finds her scope of care narrowing considerably as the healthcare landscape changes, leaving her contemplating her future as a physician.

Slide Show: FDA drug approvals in the second quarter 2017 included these 10 for conditions seen in the primary care setting.

Using PET or CSF assay to detect amyloid plaques in asymptomatic adults may help detect future cognitive decline.

It'd be nice to ask a new patient about their family history with malpractice lawsuits. Unfortunately, that's not allowed, as this physician finds out.

©Lightspring-Shutterstock.com

A recent settlement highlights the importance of medical facilitates reporting a breach of protected health information in a timely manner.

Adding nintedanib to pemetrexed/cisplatin improved the progression-free survival of patients with malignant pleural mesothelioma compared with placebo.

Undergoing autologous hematopoietic stem cell transplantation was effective and safe in patients with refractory multiple myeloma, including those patients who are refractory to both proteasome inhibitors and immunomodulatory agents.

After extended follow-up, the KEYNOTE-052 study has shown that first-line pembrolizumab offers durable responses and no new safety signals in patients with cisplatin-ineligible advanced urothelial cancer.

Pages

Subscribe to No name on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.